Catalyst Pharm Inc (NQ: CPRX )

4.920 USD -0.130 (-2.57%)

Streaming Delayed Price Updated: 12:43 PM EDT, Sep 20, 2021 Add to My Watchlist

Price and Volume

Volume	408,976
Open	4.980
Bid (Size)	4.910 (12)
Ask (Size)	4.920 (13)
Prev. Close	5.050
Today's Range	4.890 - 5.010
52wk Range	2.880 - 6.235
Shares Outstanding	102,978,461
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Catalyst Pharmaceuticals to Participate at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

September 17, 2021

Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

September 10, 2021

Performance

YTD	+39.38%	+39.38%
1 Month	-10.71%	-10.71%
3 Month	-15.17%	-15.17%
6 Month	+4.90%	+4.90%
1 Year	+53.27%	+53.27%

More News

Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations

August 16, 2021

Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

August 09, 2021

Catalyst Pharmaceuticals to Hold Second Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 10th, 2021

July 26, 2021

Catalyst Pharmaceuticals Announces Issuance of U.S. Patent 11,060,128 a Method of Use Patent with Claims Covering Firdapse®

July 19, 2021

First Week of November 19th Options Trading For Catalyst Pharmaceuticals (CPRX)

Today 12:23 EDT

Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer

July 06, 2021

Catalyst Pharmaceuticals's Return On Capital Employed Overview

September 15, 2021

HOOD Stock: Is the Robinhood ‘Free Share of Stock’ Promotion in Danger?

August 25, 2021

IHE's Underlying Holdings Could Mean 16% Gain Potential

August 25, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.